Publications:
Our Research

Progress Towards an Improved Seasonal Influenza Vaccine: NanoFlu - Nanoparticle Influenza Vaccine (NIV)

Why Making a Diagnosis of Respiratory Syncytial Virus Should Matter to Clinicians

Progress Toward a Vaccine for Maternal Immunization to Prevent Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Infection (LRTI) in Infants

Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine

Data from Completed Phase 1/2 Trial of a Novel Recombinant Saponin-Adjuvanted tNIV

Nanoparticle Influenza Vaccine: Older Adults

RSV F Nanoparticle Vaccine: IVM

Matrix-M adjuvant enhances immunogenicity of both protein- and modified vaccinia viru Ankara-based influenza vaccines in mice

Binding Kinetics of RSV Pre-fusogenic F Nanoparticle Vaccine to Palivizumab and Serum Polyclonal Antibody

Antigenic Characterization of RSV Pre-fusogenic F Nanoparticle Vaccine, Pre-F, and Post-F Proteins against a Broad Range of Neutralizing Monoclonal Antibodies and Epitope Responses in Cotton Rats